Repeat exposure to active tuberculosis and risk of re-infection

Med J Aust. 2016 Feb 1;204(2):77-8. doi: 10.5694/mja15.00749.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antitubercular Agents / adverse effects
  • Antitubercular Agents / therapeutic use
  • Chemical and Drug Induced Liver Injury / etiology
  • Chemical and Drug Induced Liver Injury / prevention & control
  • Emergency Service, Hospital
  • Ethambutol / therapeutic use
  • Female
  • Humans
  • Isoniazid / adverse effects
  • Isoniazid / therapeutic use
  • Mycobacterium tuberculosis* / isolation & purification
  • Parents
  • Pyrazinamide / adverse effects
  • Pyrazinamide / therapeutic use
  • Recurrence
  • Rifampin / therapeutic use
  • Risk Assessment
  • Risk Factors
  • Siblings
  • Sputum / microbiology
  • Time Factors
  • Treatment Outcome
  • Tuberculosis, Pulmonary / diagnosis*
  • Tuberculosis, Pulmonary / drug therapy
  • Tuberculosis, Pulmonary / microbiology
  • Tuberculosis, Pulmonary / transmission*

Substances

  • Antitubercular Agents
  • Pyrazinamide
  • Ethambutol
  • Isoniazid
  • Rifampin